BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BINAXNOW COVID-19 AG SELF TEST 2CT

    MDR report key: 19310438 · Received May 14, 2024

    Report

    Report Number
    1221359-2024-00383
    Event Type
    Malfunction
    Date Received
    May 14, 2024
    Date of Event
    April 20, 2024
    Report Date
    May 20, 2024
    Manufacturer
    ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Product Code
    QKP
    UDI-DI
    00811877011408
    PMA / PMN Number
    EUA210264
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION.

    Additional Manufacturer Narrative · 0

    TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 233952A WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 233952A, TEST BASE PART NUMBER 195-430WL / LOT 224813. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 233952A SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024. THE CONSUMER WAS ON PAXLOVID WHEN TEST RESULT WAS NEGATIVE. REPEAT TESTING WAS PERFORMED THRICE ON (B)(6) 2024 WHICH GENERATED A POSITIVE RESULT. ADDITIONAL TESTING WAS PERFORMED TWICE : ONCE WITH TELESWAB RAPID TEST ON (B)(6) 2024 AND THE SECOND WITH IHEALTH RAPID TEST AT DOCTOR'S OFFICE ON (B)(6) 2024. BOTH METHODS GENERATED A POSITIVE RESULT. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024. THE CONSUMER WAS ON PAXLOVID WHEN TEST RESULT WAS NEGATIVE. REPEAT TESTING WAS PERFORMED THRICE ON (B)(6) 2024, (B)(6) 2024 AND (B)(6) 2024 WHICH GENERATED A POSITIVE RESULT. ADDITIONAL TESTING WAS PERFORMED TWICE : ONCE WITH TELESWAB RAPID TEST ON (B)(6) 2024 AND THE SECOND WITH IHEALTH RAPID TEST AT DOCTOR'S OFFICE ON (B)(6) 2024. BOTH METHODS GENERATED A POSITIVE RESULT. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    475757 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 233952A 00811877011408

    Patients

    Seq Age Sex Outcome Treatment
    1 72 YR Male